Halozyme Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
06.08.24
/
50%
€47.69
Target price
06.08.25
€47.59
Performance (%)
11.55%
End price
07.08.25
€53.20
Summary
This prediction ended on 07.08.25 with a price of €53.20. The prediction had a final performance of 11.55%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | 3.016% | 3.016% | 39.230% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at JPMorgan Chase & Co. from $53.00 to $52.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten